Northwestern Mutual Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Sell
579,162
-13,119
-2% -$349K 0.01% 483
2025
Q4
$14.7M Buy
592,281
+8,344
+1% +$210K 0.01% 475
2025
Q3
$14.9M Sell
583,937
-84,750
-13% -$2.09M 0.01% 469
2025
Q2
$16.2M Sell
668,687
-60,725
-8% -$1.42M 0.01% 420
2025
Q1
$18.5M Sell
729,412
-311,614
-30% -$8.15M 0.02% 360
2024
Q4
$27.6M Buy
1,041,026
+32,447
+3% +$880K 0.02% 294
2024
Q3
$29.2M Buy
1,008,579
+155,578
+18% +$4.54M 0.03% 274
2024
Q2
$23.9M Sell
853,001
-39,053
-4% -$1.08M 0.02% 290
2024
Q1
$24.8M Sell
892,054
-141,340
-14% -$3.92M 0.03% 276
2023
Q4
$29.8M Sell
1,033,394
-2,493
-0.2% -$75.4K 0.03% 249
2023
Q3
$34.4M Buy
1,035,887
+7,632
+0.7% +$270K 0.04% 205
2023
Q2
$37.7M Sell
1,028,255
-46,532
-4% -$1.81M 0.05% 187
2023
Q1
$43.9M Sell
1,074,787
-54,136
-5% -$2.34M 0.06% 157
2022
Q4
$57.8M Buy
1,128,923
+189,381
+20% +$9.08M 0.09% 120
2022
Q3
$41.1M Buy
939,542
+43,867
+5% +$2.13M 0.07% 142
2022
Q2
$47M Buy
895,675
+23,164
+3% +$1.18M 0.08% 122
2022
Q1
$45.2M Buy
872,511
+182,907
+27% +$9.49M 0.07% 135
2021
Q4
$40.7M Sell
689,604
-55,082
-7% -$2.73M 0.07% 136
2021
Q3
$32M Buy
744,686
+7,074
+1% +$313K 0.06% 149
2021
Q2
$28.9M Buy
737,612
+43,013
+6% +$1.67M 0.05% 153
2021
Q1
$25.2M Buy
694,599
+38,665
+6% +$1.37M 0.05% 151
2020
Q4
$24.1M Buy
655,934
+32,385
+5% +$1.19M 0.06% 142
2020
Q3
$21.7M Buy
623,549
+92,768
+17% +$3.25M 0.06% 134
2020
Q2
$16.5M Sell
530,781
-35,923
-6% -$1.22M 0.05% 149
2020
Q1
$17.6M Buy
566,704
+52,130
+10% +$1.78M 0.07% 124
2019
Q4
$19.1M Buy
514,574
+11,301
+2% +$403K 0.07% 130
2019
Q3
$17.2M Sell
503,273
-2,183
-0.4% -$79.4K 0.07% 132
2019
Q2
$20.8M Buy
505,456
+4,120
+0.8% +$164K 0.08% 111
2019
Q1
$20.2M Sell
501,336
-2,373
-0.5% -$95K 0.09% 105
2018
Q4
$20.9M Buy
503,709
+3,583
+0.7% +$149K 0.1% 96
2018
Q3
$20.9M Sell
500,126
-17,125
-3% -$659K 0.11% 93
2018
Q2
$17.8M Sell
517,251
-335,977
-39% -$11.5M 0.1% 94
2018
Q1
$28.7M Buy
853,228
+24,076
+3% +$828K 0.17% 63
2017
Q4
$28.5M Buy
829,152
+8,747
+1% +$298K 0.18% 65
2017
Q3
$27.8M Buy
820,405
+3,230
+0.4% +$104K 0.2% 63
2017
Q2
$26M Buy
817,175
+66,398
+9% +$2.09M 0.21% 63
2017
Q1
$24.4M Buy
750,777
+42,492
+6% +$1.34M 0.22% 64
2016
Q4
$21.8M Buy
708,285
+463,125
+189% +$14.1M 0.24% 65
2016
Q3
$7.88M Sell
245,160
-122,621
-33% -$4.1M 0.52% 44
2016
Q2
$12.3M Buy
367,781
+13,778
+4% +$440K 0.18% 95
2016
Q1
$9.96M Buy
354,003
+14,539
+4% +$415K 0.16% 107
2015
Q4
$10.4M Buy
339,464
+15,631
+5% +$492K 0.21% 93
2015
Q3
$9.65M Buy
323,833
+38,387
+13% +$1.23M 0.23% 84
2015
Q2
$9.08M Buy
285,446
+29,777
+12% +$970K 0.24% 81
2015
Q1
$8.44M Sell
255,669
-11,719
-4% -$373K 0.24% 86
2014
Q4
$7.9M Buy
267,388
+21,956
+9% +$630K 0.24% 85
2014
Q3
$6.88M Sell
245,432
-46,319
-16% -$1.3M 0.24% 86
2014
Q2
$8.21M Sell
291,751
-21,332
-7% -$608K 0.32% 67
2014
Q1
$9.54M Buy
313,083
+97,147
+45% +$2.9M 0.4% 57
2013
Q4
$6.28M Buy
215,936
+19,365
+10% +$564K 0.29% 78
2013
Q3
$5.36M Buy
196,571
+3,495
+2% +$95.1K 0.28% 78
2013
Q2
$5.13M Buy
+193,076
New +$5.33M 0.31% 72

Other funds holding PFE

Northwestern Mutual Wealth Management's PFE Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Pfizer (PFE) stake by 2.2% in Q1 2026, selling an estimated $349K and leaving 579,162 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #483.

Northwestern Mutual Wealth Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.8M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Northwestern Mutual Wealth Management held 579,162 shares of Pfizer worth $16.3M as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 13,119 Pfizer shares in Q1 2026, an estimated $349K.
  • Pfizer made up 0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #483 holding.
  • Northwestern Mutual Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Northwestern Mutual Wealth Management's Pfizer position peaked at $57.8M in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.